In what strengths is duloxetine (Cymbalta) available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duloxetine Available Strengths

Duloxetine is available in three strengths: 20 mg, 30 mg, and 60 mg delayed-release capsules. 1

FDA-Approved Formulations

According to the FDA drug label, duloxetine hydrochloride delayed-release capsules are available as: 1

  • 20 mg capsules: Green opaque/green opaque, size '4' hard gelatin capsule filled with white to off-white pellets, imprinted with 'X' on cap and '01' on body with black ink 1

  • 30 mg capsules: Blue opaque/white opaque, size '3' hard gelatin capsule filled with white to off-white pellets, imprinted with 'X' on blue cap and '02' on white body with black ink 1

  • 60 mg capsules: Blue opaque/green opaque, size '1' hard gelatin capsule filled with white to off-white pellets, imprinted with 'X' on blue cap and '03' on green body with black ink 1

Clinical Dosing Context

The 30 mg and 60 mg strengths are the most commonly prescribed formulations in clinical practice: 2

  • Standard starting dose: 30 mg once daily for one week, then increase to 60 mg once daily 3, 2

  • Therapeutic dose for most indications: 60 mg once daily is the target maintenance dose for major depressive disorder, diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain 3, 4

  • Maximum approved dose: 120 mg daily (administered as 60 mg twice daily) 3, 5

The 20 mg strength is less commonly used but provides flexibility for dose adjustments in special populations or when tapering the medication. 2

References

Guideline

Duloxetine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Duloxetine Administration and Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Safety and adverse event profile of duloxetine.

Expert opinion on drug safety, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.